Trump has increased pressure on Senate Republicans to end the shutdown — now at 37 days, the longest in U.S. history ...

Despite decades of efforts to improve school attendance and truancy, a KXAN investigation found Texas doesn’t track student ...

After soaring roughly 400% over the past year, however, shares of Palantir took a time out on Monday despite the strong results. The stock initially rose after the earnings were released on Monday, ...

Elections this week that energized Democrats and angered President Donald Trump have cast a chill over efforts to end the ...

Within hours of Zohran Mamdani’s election as New York’s first Muslim mayor, there were swift and harsh reactions from his ...

23, Trump suggested on social media that Ukraine might be able “to take back their Country in its original form and, who knows ... These comments follow the administration’s extrajudicial killings at ...

A report that the administration is in talks for the government to take equity stakes in quantum computing companies is not necessarily something the Trump administration is considering, according to ...

A group of Democratic state governors has launched a new alliance aimed at coordinating their public health efforts. They’re framing it as a way to share data, messages about threats, emergency ...

President Donald Trump’s administration is facing backlash from liberals after it revoked visas from at least six foreigners over speech related to the late right-wing activist Charlie Kirk. “The ...

The layoffs have raised fears that the administration could be effectively ending an initiative that provides contraception for millions of low-income women. By Caroline Kitchener Reporting from ...

Mr. Mangano served as the executive director of the United States Interagency Council on Homelessness under President George W. Bush. It’s bad enough that the number of homeless people in the United ...

Natera Inc. (NASDAQ:NTRA) is one of the best growth stocks to buy now. On September 30, Natera announced the publication of a validation study for its personalized molecular residual disease test, ...